Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Hims guides Q1 revenue below expectations with sharp EPS drop amid market volatility.
HIMS
$28.09
-$4.65 -14.20%

Hims guides Q1 revenue below expectations with sharp EPS drop amid market volatility.

Company Fundamentals
05 May 2026
Seeking Alpha
View Source
Neutral
pluang ai news

Hims & Hers Health forecasted Q1 revenue between $600 million and $625 million, slightly below the Street's $616–650 million estimate, impacted by a $65 million GLP-1 headwind. The company expects GAAP EPS to fall about 83% year-over-year to roughly $0.03, signaling a margin reset already factored into current estimates. Despite this, short interest remains high at about 34% of the float, with 2–3 days to cover, suggesting potential for increased stock volatility. Valuation metrics stand at approximately 2.3 times 2026 sales and 53 times forward P/E, indicating the need for business stabilization and margin recovery to justify current prices.

More News (HIMS)

Hims & Hers Health upgraded to Buy on strong operational focus and growth plans despite sector challenges

Hims & Hers Health upgraded to Buy on strong operational focus and growth plans despite sector challenges

Hims & Hers Health has been upgraded from Hold to Buy due to its disciplined operations and strategic growth in personalized treatments and telehealth. The company leverages FDA panel momentum on peptides and emphasizes clinical rigor and supply chai...

Analyst Insights
Bullish
2 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App